Remedy Cure India Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 21-06-2024
- Paid Up Capital ₹ 2.00 M
as on 21-06-2024
- Company Age 11 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.78 M
as on 21-06-2024
- Revenue 50.97%
(FY 2019)
- Profit 16.58%
(FY 2019)
- Ebitda 40.29%
(FY 2019)
- Net Worth -49.37%
(FY 2019)
- Total Assets 16.62%
(FY 2019)
About Remedy Cure India
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 2.00 M.
The company currently has active open charges totaling ₹1.78 M.
Dhirendra Jha, Surendar Jha, and Mamta Jha serve as directors at the Company.
- CIN/LLPIN
U24297DL2013PLC249341
- Company No.
249341
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
12 Mar 2013
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
West Delhi, Delhi, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Remedy Cure India Limited offer?
Remedy Cure India Limited offers a wide range of products and services, including .
Who are the key members and board of directors at Remedy Cure India?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Dhirendra Jha  | Director | 12-Mar-2013 | Current |
| Surendar Jha | Director | 12-Mar-2013 | Current |
| Mamta Jha | Director | 12-Mar-2013 | Current |
Financial Performance and Corporate Structure Insights of Remedy Cure India.
Remedy Cure India Limited, for the financial year ended 2019, experienced significant growth in revenue, with a 50.97% increase. The company also saw a substantial improvement in profitability, with a 16.58% increase in profit. The company's net worth observed a substantial decline by a decrease of 49.37%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Remedy Cure India?
In 2019, Remedy Cure India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 17 May 2022 | ₹1.78 M | Open |
How Many Employees Work at Remedy Cure India?
Remedy Cure India has a workforce of 5 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Remedy Cure India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Remedy Cure India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
